Speaker(s):
Dr. Amit Sharma, MD, MPH, FRCP, FIDSA- has nothing to disclose
Moderator(s):
Anil Singh, MD, Staff Member, Geisinger - has nothing to disclose.
Objectives:
- to understand the process by explaining how blood cultures are collected, processed, and reported in the lab
- to Interpret results by teaching the audience how to interpret blood culture results, including timing, organism identification, and susceptibility patterns
- to differentiate contamination vs. infection by providing tools to distinguish between contaminated cultures and true bacteremia
- to manage positive cultures by discussing management strategies for common positive blood culture scenarios (e.g., Staphylococcus aureus, coagulase-negative staphylococci, gram-negative rods)
to apply knowledge practically by using real-world scenarios to reinforce decision-making
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Anil Kumar Singh, MD, Roop Parlapalli, MD, FHM, FACP, Lakshmi Rani Gollamudi, MD, Christopher DeFrancesco PharmD, RPH, Mary Ellen Berry, PA-C, and Carlena Miller, CRNP have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
Session date:
04/18/2025 - 12:00pm to 1:00pm EDT
Location:
Geisinger Community Medical Center
1800 Mulberry Street
Scranton 18510
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward